Open access
Open access
Powered by Google Translator Translator

Covid-19 (Public Health Issues)

Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest

3 Mar, 2021 | 08:51h | UTC

Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest – The BMJ

 

Commentary on Twitter

 


How to make ‘immunity passports’ more ethical

3 Mar, 2021 | 08:46h | UTC

How to Make ‘Immunity Passports’ More Ethical – Scientific American

Related: Twelve criteria for the development and use of COVID-19 vaccine passports

 


Another study shows higher antibody titer responses to a single dose of mRNA vaccine among patients with previous COVID-19 infection

2 Mar, 2021 | 02:13h | UTC

Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2 – JAMA

Related: Studies: Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection (studies and commentary)

 


WHO: Roadmap to improve and ensure good indoor ventilation in the context of COVID-19

2 Mar, 2021 | 02:15h | UTC

Roadmap to improve and ensure good indoor ventilation in the context of COVID-19 – World Health Organization

 

Commentary on Twitter

 


Scaling up COVID-19 rapid antigen tests: promises and challenges

2 Mar, 2021 | 02:09h | UTC

Scaling up COVID-19 rapid antigen tests: promises and challenges – The Lancet Infectious Diseases

 


Vaccinating the oldest against COVID-19 saves both the most lives and most years of life

2 Mar, 2021 | 02:04h | UTC

Vaccinating the oldest against COVID-19 saves both the most lives and most years of life – Proceedings of the National Academy of Sciences

Commentary: Vaccinating Oldest First for COVID Saves the Most Lives: Study – HealthDay

 

Commentary on Twitter

 


Who gets a COVID-19 vaccine and who pays? The need for economic analysis

2 Mar, 2021 | 02:02h | UTC

Who Gets a COVID-19 Vaccine and Who Pays? The Need for Economic Analysis – Center for Global Development

 

Commentary on Twitter

 


CDC Report: Reduction in severe COVID-19 following the implementation of a national vaccination program in Israel

28 Feb, 2021 | 21:54h | UTC

Reduction in COVID-19 Patients Requiring Mechanical Ventilation Following Implementation of a National COVID-19 Vaccination Program — Israel, December 2020–February 2021 – CDC Morbidity and Mortality Weekly Report

Commentary: Israeli data suggest mass vaccinations led to drop in severe Covid cases, CDC study finds – CNBC

 

Commentary on Twitter

 


CDC Study: Suspected SARS-CoV-2 reinfections in a skilled nursing facility

28 Feb, 2021 | 21:55h | UTC

Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: Possible SARS-CoV-2 Reinfection Described at Skilled Nursing Facility – HealthDay AND Reinfections could be more likely among those with a mild first case of COVID-19: case study – CTV News

 

Commentary on Twitter (thread – Click for more)

 


Short Review: SARS-CoV-2 Vaccines

28 Feb, 2021 | 21:52h | UTC

SARS-CoV-2 Vaccines – JAMA

Author interview: Coronavirus Vaccines—An Overview

 

 


Studies: Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection

28 Feb, 2021 | 21:49h | UTC

Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection – Imperial College London

Study 1: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals – The Lancet

Study 2: Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine – The Lancet

 

Commentary on Twitter (thread – click for more)

 


Spain to give just one vaccine dose to under 55-year olds who had COVID-19

28 Feb, 2021 | 21:47h | UTC

Spain to give just one vaccine dose to under 55-year olds who had COVID-19 – Reuters

Related: Is One Vaccine Dose Enough After COVID-19 Infection? – NIH Director’s Blog AND France’s health authority recommends single vaccine shot for people who have had COVID-19

 


Long Read | 5 Pandemic Mistakes We Keep Repeating

28 Feb, 2021 | 21:43h | UTC

5 Pandemic Mistakes We Keep Repeating – The Atlantic (a few articles per month are free)

 


WHO Report: Preparing for Long COVID 2021

26 Feb, 2021 | 08:46h | UTC

In the wake of the pandemic: preparing for Long COVID (2021) – World Health Organization

News release: New policy brief calls on decision-makers to support patients as 1 in 10 report symptoms of “long COVID” – World Health Organization

Commentaries: Long COVID sufferer still has disease’s debilitating symptoms nearly a year after first falling ill – EuroNews AND Debilitating ‘long-COVID’ may have severe health, social impacts: WHO – Reuters

Related: Dr. Fauci says new data suggests ‘long’ Covid symptoms can last up to 9 months – CNBC

 


CDC studies on superspreading events at fitness facilities

26 Feb, 2021 | 08:44h | UTC

Study 1: COVID-19 Outbreak Among Attendees of an Exercise Facility — Chicago, Illinois, August–September 2020 – CDC Morbidity and Mortality Weekly Report

Study 2: Community Transmission of SARS-CoV-2 at Three Fitness Facilities — Hawaii, June–July 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: Going maskless is a key factor in Covid-19 outbreaks at gyms, studies say – CNN AND A Chicago gym saw dozens of COVID-19 cases after infected people attended HIIT classes without masks – Insider

 


New protocol tested SARS-CoV-2 positivity on day 9 among quarantined student contacts of confirmed cases, resulting in safe reduction in loss of instructional time

26 Feb, 2021 | 08:42h | UTC

SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases – JAMA

Commentary: Is the CDC 10-day COVID-19 quarantine guideline enough? – News Medical

 

Commentary on Twitter

 


Study finds increased COVID-19 mortality among adults with Down syndrome

26 Feb, 2021 | 08:39h | UTC

Medical vulnerability of individuals with down syndrome to severe COVID-19 – data from the trisomy 21 research society and the UK ISARIC4C survey – EClinicalMedicine

Commentaries: Adults with Down syndrome 3 times more likely to die of COVID, study finds – CIDRAP AND International study finds increased COVID-19 mortality among adults with Down syndrome – Case Western Reserve University

Related: COVID-19 is 10 times deadlier for people with Down syndrome, raising calls for early vaccination – Science (a few articles per month are free)

 


COVID-19 hospitalizations attributable to cardiometabolic conditions

26 Feb, 2021 | 08:40h | UTC

Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis – Journal of the American Heart Association

Commentary: Study estimates two-thirds of COVID-19 hospitalizations due to four conditions – Tufts University

 

Commentary on Twitter

 


Opinion – Catching COVID from surfaces is very unlikely. So perhaps we can ease up on the disinfecting

26 Feb, 2021 | 08:38h | UTC

Catching COVID from surfaces is very unlikely. So perhaps we can ease up on the disinfecting – The Conversation

Related: Coronavirus is in the air — there’s too much focus on surfaces – Nature AND COVID-19 rarely spreads through surfaces. So why are we still deep cleaning? – Nature

 


Real-world data confirms Pfizer-BioNTech vaccine effectiveness

25 Feb, 2021 | 09:09h | UTC

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting – New England Journal of Medicine

Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination – New England Journal of Medicine

Commentaries: Real-world trial of Pfizer COVID vaccine finds high 2-dose, good 1-dose protection – CIDRAP AND Pfizer-BioNTech vaccine performs as well in the real world as in clinical trials, new study concludes – STAT AND In boost for COVID-19 battle, Pfizer vaccine found 94% effective in real world – Reuters AND Expert reaction to NEJM paper on Pfizer-BioNTech vaccine roll-out in Israel and COVID-19 outcomes – Science Media Centre

 

Commentary on Twitter (thread – click for more)

 


Ghana receives first historic shipment of COVID-19 vaccinations from international COVAX facility

25 Feb, 2021 | 09:12h | UTC

Ghana receives first historic shipment of COVID-19 vaccinations from international COVAX facility – UN News

See also: Ghana becomes recipient of historic first shipment of COVAX vaccines – World Health Organization

Commentaries: Covax vaccine-sharing scheme delivers first doses to Ghana – BBC AND Covax delivers first Covid vaccines in ‘momentous occasion’ – The Guardian AND COVAX delivers its first vaccine shots with shipment to Ghana – Reuters

 


[Not published yet] Covid-19 vaccine made by China’s Sinopharm has an efficacy rate of 72.5 percent

25 Feb, 2021 | 09:07h | UTC

Covid-19 vaccines made by China’s Sinopharm, CanSino release efficacy data – South China Morning Post

See also: Sinopharm’s Wuhan unit reports 72.5% efficacy for COVID shot, seeks approval in China – Reuters

 

Commentary on Twitter

 


FDA scientists endorse J&J’s Covid vaccine, as new data shed light on efficacy

25 Feb, 2021 | 09:06h | UTC

FDA scientists endorse J&J’s Covid vaccine, as new data shed light on efficacy – STAT

See also: FDA says single-dose shot from J&J prevents severe COVID – MedicalXpress

 


People with SARS-CoV-2 antibodies may have a low risk of future infection

25 Feb, 2021 | 09:04h | UTC

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection – JAMA Internal Medicine

Editorial: How to Advise Persons Who Are Antibody Positive for SARS-CoV-2 About Future Infection Risk

Commentaries: Covid-19 antibodies may protect against reinfection later, study suggests – CNN AND NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection – National Cancer Institute

 


Massive Google-funded COVID database will track variants and immunity

25 Feb, 2021 | 09:03h | UTC

Massive Google-funded COVID database will track variants and immunity – Nature

See also: Backed by Google, epidemiologists launch a sweeping Covid-19 data platform – STAT

 


Stay Updated in Your Specialty

No spam, just news.